Mahnoor Rehan Hashmi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mahnoor Rehan Hashmi has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Yumna Khabir
Department of Medicine Dow University of Health Sciences Karachi Pakistan
6 shared publications - Adam Ali Asghar
Department of Medicine, Dow University of Health Sciences, Mission Rd, New Labour Colony Nanakwara, Karachi, Sindh, Pakistan
5 shared publications - Muhammad Junaid Tahir
Department of Radiology, Research Centre, Shaukat Khanam Memorial Cancer Hospital, Lahore, Pakistan
2 shared publications - Syeda Tayyaba Rehan
Dow University of Health Sciences, Karachi, Pakistan
2 shared publications - Aiman Rija
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan
1 shared publication Ali Abbas Mankani
5th Year MBBS Student, Dow University of Health Sciences, Karachi, Pakistan
1 shared publication
Latest Publications
- 16 April 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (7) , 163145
Surgical management of pilonidal sinus disease in pediatric population: An updated systematic review and meta-analysis
- 16 April 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (7) , 163145
Surgical management of pilonidal sinus disease in pediatric population: An updated systematic review and meta-analysis
- Open Access
- 26 March 2026
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 76 (04) , 577-582
Breast cancer in Pakistan: current status of screening, diagnosis, and management - a review
Pakistan has one of the highest rates of breast cancer in Asia, and the latest demographic trends show that this rate is likely to escalate further. In South Asian women, cultural practices and assumptions play a significant role in their understanding of cancer prevention, emphasising the importance of host country cultures and healthcare systems. Another significant issue is the lack of satisfactory screening modalities and knowledge among healthcare workers, particularly nurses. Exploring these factors in detail is crucial for optimising outcomes and enhancing patient care. The current narrative review was planned to deliver a comprehensive understanding of the various factors that lead to the rising prevalence of breast cancer in Pakistan, and to analyse their potential impact on the screening, diagnosis and treatment of this potentially life-threatening disease. To counter the delayed diagnosis and treatment of breast cancer cases, awareness campaigns and education programmes regarding breast cancer should be conducted at the community and institutional levels. Key Words: Breast cancer, Pakistan, Screening, Diagnosis, Treatment.
- 26 March 2026
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 76 (04) , 577-582
Open AccessBreast cancer in Pakistan: current status of screening, diagnosis, and management - a review
Pakistan has one of the highest rates of breast cancer in Asia, and the latest demographic trends show that this rate is likely to escalate further. In South Asian women, cultural practices and assumptions play a significant role in their understanding of cancer prevention, emphasising the importance of host country cultures and healthcare systems. Another significant issue is the lack of satisfactory screening modalities and knowledge among healthcare workers, particularly nurses. Exploring these factors in detail is crucial for optimising outcomes and enhancing patient care. The current narrative review was planned to deliver a comprehensive understanding of the various factors that lead to the rising prevalence of breast cancer in Pakistan, and to analyse their potential impact on the screening, diagnosis and treatment of this potentially life-threatening disease. To counter the delayed diagnosis and treatment of breast cancer cases, awareness campaigns and education programmes regarding breast cancer should be conducted at the community and institutional levels. Key Words: Breast cancer, Pakistan, Screening, Diagnosis, Treatment.
- 29 August 2025
- Published by One Surgery
- No. 1
Unmasking the Divide: Racial Disparities in Breast Cancer Mortality as a Marker of Systemic Gaps in Surgical and Oncologic Access
Background and Objective: Breast cancer remains a leading cause of cancer related mortality in women, with significant disparities among ethnic groups. This study examines trends in breast cancer incidence and mortality in the U.S., focusing on racial disparities and areas for improving cancer control and equity. Methodology: Data from the SEER Program (2010–2022) was used to examine incidence rates based on race and age. Mortality trends from 1999 to 2020 were assessed using the CDC WONDER database, stratified by race. Results: Between 2010-2015, the overall incidence of HER2+/HR+ breast cancer showed an upward trend, which reversed from 2016-2022. Notably, Black women experienced the most statistically significant drop in incidence during 2018-2022, with an Annual Percent Change of -2.3% (p value: 0.02%). Age-specific analyses revealed a significant rise in women aged 50-64 and 65+ from 2010-2016, followed by a decline with Annual Percent Changes of -1.9% and -2.0%, respectively. Racial trends reflect a shift from rising to falling incidence, particularly in older age groups, signaling potential improvements in prevention and early detection. The Age-Adjusted Mortality Rate (AAMR) among Black women declined notably from 27.58 in 2010 to 22.74 in 2020, but remained considerably higher than other groups. In comparison, 2020 AAMRs were 15.69 for White women, 9.75 for Asian women, and 8.56 for American Indian women. Conclusion: Despite improvements in breast cancer incidence, disparities in mortality persist, highlighting the need for transdisciplinary solutions. Collaboration across oncology, surgery, and public health is vital to address systemic gaps and ensure equitable healthcare access for all, particularly marginalized racial groups.
- 29 August 2025
- Published by One Surgery
- No. 1
Unmasking the Divide: Racial Disparities in Breast Cancer Mortality as a Marker of Systemic Gaps in Surgical and Oncologic Access
Background and Objective: Breast cancer remains a leading cause of cancer related mortality in women, with significant disparities among ethnic groups. This study examines trends in breast cancer incidence and mortality in the U.S., focusing on racial disparities and areas for improving cancer control and equity. Methodology: Data from the SEER Program (2010–2022) was used to examine incidence rates based on race and age. Mortality trends from 1999 to 2020 were assessed using the CDC WONDER database, stratified by race. Results: Between 2010-2015, the overall incidence of HER2+/HR+ breast cancer showed an upward trend, which reversed from 2016-2022. Notably, Black women experienced the most statistically significant drop in incidence during 2018-2022, with an Annual Percent Change of -2.3% (p value: 0.02%). Age-specific analyses revealed a significant rise in women aged 50-64 and 65+ from 2010-2016, followed by a decline with Annual Percent Changes of -1.9% and -2.0%, respectively. Racial trends reflect a shift from rising to falling incidence, particularly in older age groups, signaling potential improvements in prevention and early detection. The Age-Adjusted Mortality Rate (AAMR) among Black women declined notably from 27.58 in 2010 to 22.74 in 2020, but remained considerably higher than other groups. In comparison, 2020 AAMRs were 15.69 for White women, 9.75 for Asian women, and 8.56 for American Indian women. Conclusion: Despite improvements in breast cancer incidence, disparities in mortality persist, highlighting the need for transdisciplinary solutions. Collaboration across oncology, surgery, and public health is vital to address systemic gaps and ensure equitable healthcare access for all, particularly marginalized racial groups.
- Open Access
- 28 March 2025
- Published by Springer Nature in Discover Public Health
- Vol. 22 (1) , 1-3
Cupping the future: highlighting the importance of menstrual cups and the prevailing challenges to its use in Pakistani women
- 28 March 2025
- Published by Springer Nature in Discover Public Health
- Vol. 22 (1) , 1-3
Open AccessCupping the future: highlighting the importance of menstrual cups and the prevailing challenges to its use in Pakistani women
- Open Access
- 4 October 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (11) , 5584-5592
Odds of HIV among incarcerated drug users: a systematic review and meta-analysis of Asian countries
Background: HIV makes up a large portion of infectious diseases globally. People injecting drugs in prisons are at high risk for contracting HIV infection. Prisons house ~10.2 million people globally, making them a high-risk setting for HIV transmission. This systematic review summarizes the available data on the odds of developing HIV infection among imprisoned people who inject drugs (PWIDs) in Asian regions. Methods: The authors electronically assessed published studies from January, 2000 to December, 2022, including studies that investigated the odds of HIV in imprisoned PWIDs. We extensively searched PubMed, ERIC, and Cochrane Central and Google Scholar with no constraints in language or time. All the observational studies evaluating the chances of HIV in Asian prisoners with an exposure group of PWIDs and a control group of non-injecting-drug users were included in our analysis. Results: The databases search yielded 254 potential studies, 10 observational studies of which having a total of 17 333 participants were included. A low or moderate risk of bias was reported in all the studies except one case-control. The pooled analysis showed a significant association between PWIDs and the chances of contracting HIV infection (Odds ratio=6.40; 95% CI=3.89–10.52; P2=53%). Conclusion: This study found a vital correlation between injecting-drug usage during imprisonment and HIV transmission speed. The results of this meta-analysis support the need to prevent HIV and conducting treatment programs in high-risk settings like prisons.
- 4 October 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (11) , 5584-5592
Open AccessOdds of HIV among incarcerated drug users: a systematic review and meta-analysis of Asian countries
Background: HIV makes up a large portion of infectious diseases globally. People injecting drugs in prisons are at high risk for contracting HIV infection. Prisons house ~10.2 million people globally, making them a high-risk setting for HIV transmission. This systematic review summarizes the available data on the odds of developing HIV infection among imprisoned people who inject drugs (PWIDs) in Asian regions. Methods: The authors electronically assessed published studies from January, 2000 to December, 2022, including studies that investigated the odds of HIV in imprisoned PWIDs. We extensively searched PubMed, ERIC, and Cochrane Central and Google Scholar with no constraints in language or time. All the observational studies evaluating the chances of HIV in Asian prisoners with an exposure group of PWIDs and a control group of non-injecting-drug users were included in our analysis. Results: The databases search yielded 254 potential studies, 10 observational studies of which having a total of 17 333 participants were included. A low or moderate risk of bias was reported in all the studies except one case-control. The pooled analysis showed a significant association between PWIDs and the chances of contracting HIV infection (Odds ratio=6.40; 95% CI=3.89–10.52; P2=53%). Conclusion: This study found a vital correlation between injecting-drug usage during imprisonment and HIV transmission speed. The results of this meta-analysis support the need to prevent HIV and conducting treatment programs in high-risk settings like prisons.
- 21 November 2022
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 41 (4) , 620-622
Patients with obesity face greater barrier to health care management than patients with normal body mass index: growing evidence
Dear Editor, We read with great interest the article by Gimenez et al. which evaluated the impact of weight and body mass index (BMI) of patients on patient–general practitioner (GP) interaction.1 The interaction was calculated on basis of the degree of disagreement between patients and GP.1 The data were collected from the quantitative phase of the INTERMEDE project. The INTERMEDE project is a multidisciplinary project that identifies the nature of patient–GP interaction and its impact on social health discrepancies.1 Patients and GPs responded to mirrored questionnaires about perceptions on information and advice given at the end of the consultation to determine disagreement which was the primary outcome of the study. According to the questionnaire, the GP advised being physically active, maintaining a nutritious diet, limiting alcohol consumption, etc.1 Discordant pairs of answers (i.e. “GP = yes, patient = no” or “GP = no, patient = yes”) for a number of questions were selected, and used to define disagreement. 2 explanatory variables were considered.1 The first was patients’ BMI categorized according to WHO recommendation and second was the difference in BMI categories between patient and GP, created with the formula: “weight difference” = patient’s BMI category—GP’s BMI category.1 The sole aim of this variable was to estimate the effect of a body size difference on the agreement of patient–GP pairs and to specify the statistical interaction between the patient’s BMI and the GP’s BMI.1
- 21 November 2022
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 41 (4) , 620-622
Patients with obesity face greater barrier to health care management than patients with normal body mass index: growing evidence
Dear Editor, We read with great interest the article by Gimenez et al. which evaluated the impact of weight and body mass index (BMI) of patients on patient–general practitioner (GP) interaction.1 The interaction was calculated on basis of the degree of disagreement between patients and GP.1 The data were collected from the quantitative phase of the INTERMEDE project. The INTERMEDE project is a multidisciplinary project that identifies the nature of patient–GP interaction and its impact on social health discrepancies.1 Patients and GPs responded to mirrored questionnaires about perceptions on information and advice given at the end of the consultation to determine disagreement which was the primary outcome of the study. According to the questionnaire, the GP advised being physically active, maintaining a nutritious diet, limiting alcohol consumption, etc.1 Discordant pairs of answers (i.e. “GP = yes, patient = no” or “GP = no, patient = yes”) for a number of questions were selected, and used to define disagreement. 2 explanatory variables were considered.1 The first was patients’ BMI categorized according to WHO recommendation and second was the difference in BMI categories between patient and GP, created with the formula: “weight difference” = patient’s BMI category—GP’s BMI category.1 The sole aim of this variable was to estimate the effect of a body size difference on the agreement of patient–GP pairs and to specify the statistical interaction between the patient’s BMI and the GP’s BMI.1
- Open Access
- 13 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82, 104624
Zynteglo: Betibeglogene autotemcel – An innovative therapy for β- thalassemia patients
- 13 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82, 104624
Open AccessZynteglo: Betibeglogene autotemcel – An innovative therapy for β- thalassemia patients
- Open Access
- 13 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82, 104629
Rapid-acting oral drug (Auvelity) for major depressive disorder
- 13 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82, 104629
Open AccessRapid-acting oral drug (Auvelity) for major depressive disorder
- Open Access
- 12 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82, 104627
FlexBurst360 therapy - A new spine cord stimulation system (SCS) for patients with chronic pain
- 12 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82, 104627
Open AccessFlexBurst360 therapy - A new spine cord stimulation system (SCS) for patients with chronic pain
- Open Access
- 10 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82, 104625
Kyzatrex - Oral testosterone replacement therapy
- 10 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82, 104625
Open AccessKyzatrex - Oral testosterone replacement therapy